Nanovibronix Inc
Change company Symbol lookup
Select an option...
NAOV Nanovibronix Inc
LFLY Leafly Holdings Inc
CPSI Computer Programs and Systems Inc
TKNO Alpha Teknova Inc
BTM Bitcoin Depot Inc
RC Ready Capital Corp
NEOV NeoVolta Inc
SCHL Scholastic Corp
SIDU Sidus Space Inc
MGY Magnolia Oil & Gas Corp
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Health Care Equipment & Supplies | Small Cap Value

NanoVibronix, Inc. is a medical device company. The Company is focused on developing noninvasive biological response-activating devices utilizing its low-intensity surface acoustic wave (SAW) technology. Its primary products consist of UroShield and PainShield. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use, which markets in the United States under Food and Drug Administration (FDA) policy of enforcement discretion during the COVID-19 pandemic and is undergoing clinical testing. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. Its PainShield family of products includes PainShield MD and PainShield Plus.

Closing Price: $2.33

Day's Change: -0.19 (-7.54%)

Bid: --

Ask: --

B/A Size: --

Day's High: 2.57

Day's Low: 2.33

Volume (Heavy Day) Volume: 356,563 10-day average volume: 87,878: 356,563

September 06, 2023
8:30 am ET	NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meeting NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield(R), PainShield(R) and WoundShield(R) Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that Dr. Sandra Wilks is scheduled to...(BusinessWire)
August 30, 2023
2:29 pm ET	NanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield(R), PainShield(R) and WoundShield(R) Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has entered into definitive...(BusinessWire)
8:30 am ET	NanoVibronix Cites Positive Results from Independent Testing of UroShield NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield(R), PainShield(R) and WoundShield(R) Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today cited positive reported outcomes from a study of...(BusinessWire)
August 29, 2023
4:05 pm ET	NanoVibronix Responds to CMS' Determination for PainShield NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield(R), PainShield(R) and WoundShield(R) Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today provided a response to the recently published...(BusinessWire)
August 28, 2023
8:30 am ET	NanoVibronix Applies for Inclusion of UroShield Products in NHS Prescription Services' Drug Tariff NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield(R), PainShield(R) and WoundShield(R) Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today provided an update on its efforts to expand...(BusinessWire)
August 23, 2023
8:45 am ET	NanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield Plus NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield(R), PainShield(R) and WoundShield(R) Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has conditionally extended its...(BusinessWire)

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for varies.

Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and